Researchers say a test meant to measure risk for opioid use disorder may cause harm. Their arguments are part of a larger debate about using genetic information to guide clinical care.
A recent TV advertisement sought clients for a class action suit against a pharmaceutical manufacturer over medication side effects, FDA approval, and patient choice in medication use.
The watchdog group Public Citizen is calling for the prompt removal of the ALS drug Relyvrio after it failed to meet primary and secondary endpoints in top-line results from a phase 3 trial.
21st Century Cures Act reboot keeps controversial changes for FDA modernhealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernhealthcare.com Daily Mail and Mail on Sunday newspapers.